Vident Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,634	Closed	-$11.2M	–	806
2023 Q2	$11.2M	Sell	15,634 -4,650	-23%	-$3.59M	0.39%	60
2023 Q1	$16.7M	Buy	20,284 +1,679	+9%	+$1.27M	0.54%	31
2022 Q4	$13.4M	Buy	18,605 +9,755	+110%	+$7.2M	0.51%	32
2022 Q3	$5.79M	Sell	8,850 -9,897	-53%	-$6.23M	0.19%	147
2022 Q2	$11.1M	Buy	18,747 +9,768	+109%	+$6.35M	0.33%	66
2022 Q1	$6.27M	Sell	8,979 -4,634	-34%	-$2.93M	0.16%	146
2021 Q4	$8.6M	Sell	13,613 -2,355	-15%	-$1.45M	0.22%	89
2021 Q3	$9.66M	Buy	15,968 +3,100	+24%	+$1.92M	0.29%	66
2021 Q2	$7.19M	Sell	12,868 -1,640	-11%	-$831K	0.22%	78
2021 Q1	$6.86M	Buy	14,508 +4,834	+50%	+$2.35M	0.23%	76
2020 Q4	$4.67M	Buy	9,674 +1,419	+17%	+$766K	0.19%	90
2020 Q3	$4.62M	Buy	8,255 +493	+6%	+$299K	0.23%	87
2020 Q2	$4.84M	Buy	7,762 +10	+0.1%	+$5.68K	0.25%	78
2020 Q1	$3.79M	Buy	7,752 +3,276	+73%	+$1.35M	0.25%	77
2019 Q4	$1.68M	Sell	4,476 -443	-9%	-$149K	0.1%	301
2019 Q3	$1.36M	Sell	4,919 -169	-3%	-$50K	0.12%	129
2019 Q2	$1.59M	Buy	5,088 +655	+15%	+$218K	0.13%	110
2019 Q1	$1.82M	Sell	4,433 -88	-2%	-$36.2K	0.1%	309
2018 Q4	$1.69M	Buy	4,521 +3,209	+245%	+$1.17M	0.09%	293
2018 Q3	$530K	Sell	1,312 -402	-23%	-$153K	0.02%	670
2018 Q2	$591K	Sell	1,714 -279	-14%	-$87.3K	0.02%	598
2018 Q1	$637K	Sell	1,993 -175	-8%	-$60.9K	0.03%	512
2017 Q4	$815K	Buy	2,168 +1,720	+384%	+$697K	0.04%	412
2017 Q3	$200K	Buy	+448	New	+$213K	0.01%	716
2015 Q3	–	Sell	-10	Closed	-$5K	–	1136
2015 Q2	$5K	Buy	+10	New	+$4.88K	﹤0.01%	1016